The present disclosure provides a compound for use in therapeutic and/or prophylactic treatment of non-alcoholic steatohepatitis (NASH) and/or alcoholic steatohepatitis (ASH). The compound for use according to the invention, is an unsaturated fatty acid with an oxygen incorporated in the β-position, and further comprising an α-substituent. More particularly, the invention provides a compound for use in treatment of NASH and/or ASH, and a method using this, wherein the compound is of Formula (II), wherein R1, R2, R3, X, and Y are as defined in the specification; and wherein this compound may be administered alone or in combination with an additional active agent.
本公开提供了一种用于治疗和/或预防非
酒精性脂肪肝炎(NASH)和/或
酒精性脂肪肝炎(ASH)的化合物。根据本发明使用的化合物是一种在β位含有氧原子的不饱和
脂肪酸,并且还包含一个α-取代基。更具体地说,本发明提供了一种用于治疗NASH和/或ASH的化合物以及使用该方法,其中该化合物是公式(II),其中R1、R2、R3、X和Y如说明书中所定义;并且该化合物可以单独使用或与另一种活性剂结合使用。